|
|
Pharmacoeconomic Evaluations: A review of drug treatments in Alzheimer's diseasePublished by: Datamonitor Published: Dec. 10, 2001 - 38 Pages Table of ContentsEXECUTIVE SUMMARY SCOPE Alzheimer's disease profile CURRENT DRUG TREATMENTS Key facts Clinical trials Cost burden of AD The introduction of pharmacoeconomics Types of pharmacoeconomic evaluations Methods and data sources in pharmacoeconomics REVIEW OF ECONOMIC EVALUATIONS Comparator Outcome measurements Perspective Identifying cost burdens Duration of effect Sensitivity analysis Withdrawals from studies Generalizability of findings KEY CONCLUSIONS AND OPPORTUNITIES Conclusions Opportunities APPENDIX Outcome measurement scales Bibliography Disease overview Clinical trials Pharmacoeconomic trials DATAMONITOR HEALTHCARE (c) Datamonitor 2001. All Rights Reserved. AbstractDatamonitor reviews recent pharmacoeconomic evaluations of drug treatments for Alzheimer's disease with a particular focus on methodology and study design. Components of the studies are critically reviewed with regards to the optimal approach to perfoming economic analyses in Alzheimer's disease. The Brief presents the opportunities available to drug manufacturers to maximize the commercial benefits offered by the use of pharmacoeconomics in all stages of the Alzheimer's disease product lifecycle.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||